Impact of 131I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation

The purpose of this study was to determine the diagnostic value of 131I SPECT/spiral CT (SPECT/CT) on nodal staging of patients with thyroid carcinoma at the first ablative radioiodine therapy. Methods: Fifty-seven patients were studied using SPECT/CT 3–4 d after receiving 3.96 6 0.5 GBq of 131I for radioablation of thyroid remnants after a thyroidectomy for differentiated thyroid carcinoma. In addition to planar whole-body scintigraphy, SPECT/CT of the neck was performed using a hybrid camera combining a double-head SPECT camera with either a 2-slice (n5 23) or a 6-slice (n5 34) spiral CT scanner. The planar scans and the SPECT/CT images were evaluated for cervical tracer uptake independently of each other and of the clinical findings. Results: SPECT/CT led to a revision of the original diagnosis in 28 of 143 cervical foci of radioiodine uptake seen on planar imag-ing. In particular, SPECT/CT reclassified as benign 6 of 11 lesions considered to be lymph node metastases and 11 of 15 lesions considered to be indeterminate. Furthermore, SPECT/CT al-lowed the identification of 11 lymph node metastases classified as thyroid remnant or as indeterminate on planar imaging. Based on this revision, SPECT/CT yielded a gain in information on nodal stage in 20 of the 57 patients studied (35%,P, 0.03). SPECT/CT altered nodal stage from N0 to N1 in 2 of 20 patients and from in-determinate (Nx) to N1 in 6 of 30 patients. The result was a change in risk stratification conforming to the classification pro-posed by the International Union Against Cancer in 14 patients (25%). Conclusion: SPECT/CT determines lymph node in-volvement at radioablation performed for thyroid cancer more accurately than does planar imaging. SPECT/CT may alter man-agement in roughly one quarter of patients with thyroid carci-noma by upstaging or downstaging their disease